Design of lipid-based nanocarrier for drug delivery has a double therapy for six common pathogens eradication

Nanostructured lipid-based carriers (NLCs) efficiently improved as potential targeted drug delivery for six common pathogens eradication. Transmission electron microscopy (TEM), scanning electron microscopy (SEM), and dynamic light scattering (DLS) showed that all the formulas fully characterized nanosize and surfacenegative charge and presented the drug's slow release even after 48 h in vitro. The biological studies proved that the nanostructures' antibacterial potency is in the order of Fe3O4

Automated summary

The study demonstrates that nanostructured lipid-based carriers (NLCs) can serve as efficient targeted drug delivery systems for eradicating six common pathogens, with slow drug release capabilities. Biological studies have shown that these nanostructures possess strong antibacterial potency.